Jay Rosenthal, President and Co-Founder of the Business of Cannabis, interviews people from all parts of the cannabis industry.
The third in our series of guest episodes features a discussion between CEO of Releaf, Tim Kirby, and Robert Jappie, Partner Fieldfisher's Regulatory Group. Tim and Robert discuss Together, they explore the disconnect between the UK's 2018 rescheduling of medical cannabis and the lack of meaningful access for patients today. Robert outlines the legal and regulatory hurdles that continue to obstruct progress, while Tim highlights the everyday impact these roadblocks have on clinics and patients. The episode also delves into the rise of self-medication and the persistent use of illicit sources. Tim and Robert examine the factors behind this trend, from affordability and education to stigma and patient trust, despite the existence of a legal framework. Finally, they unpack the complex compliance landscape for cannabis clinics in the UK. From advertising restrictions to tight prescribing protocols, the conversation reveals how clinics like Releaf build patient trust while navigating a shifting and often restrictive regulatory environment.
The second in our series of guest episodes features a discussion between CEO of Releaf, Tim Kirby, and James Duckenfield, CEO of Glass Pharms. Tim & James discuss the challenges and progress within the UK's medical cannabis industry since its legalisation in 2018, highlighting the previous stagnation due to various factors including inconsistent supply chains and a lack of a healthcare-focused approach. The discussion emphasises the importance of quality, consistency, and patient outcomes, showcasing how their collaboration aims to provide reliable medical cannabis to patients. They also touch upon the regulatory landscape, the need for better education for doctors, and the potential for significant growth in the UK market by addressing unmet healthcare needs.
Business of Cannabis: Podcast | E14
Next up we have a special episode with Tim Kirby, Chief Executive Officer with Releaf and Michael Sassano, CEO and Chairman of the Board with SOMAÍ Pharmaceuticals.
Business of Cannabis: Podcast | E12
Business of Cannabis: Podcast | E11
Business of Cannabis: Podcast | E11
Business of Cannabis: Podcast | E10
Next up is episode 9 with Andrew Lowitz, CRO, Terpene Belt Farm.Andrew Lowitz is a career Commercial Executive, Chief Revenue Officer, Executive Team Advisor and Board Member - and is responsible for strategic and operational commercial leadership, modeling and execution across Marketing, Business Development, Sales, Customer Growth/Retention. Andrew is also the Co-Founder of Cannabis Collective - a think tank community built to support leaders in the burgeoning Cannabis industry. Join us as our host Shahbaaz Kara-Virani chats with Andrew as they dig into the global terpene supply chain at Cannabis Europa 2024.www.businessofcannabis.com
Next up is episode 8 with Amy Weinstein, co-founder, Other People's Pot. Join us as our host Shahbaaz Kara-Virani chats with Amy at Cannabis Europa 2024.Business of Cannabis is a cannabis industry platform marrying cannabis news, video and podcast content, newsletters and online and real-world cannabis events. This channel highlights the cannabis companies, cannabis brands, cannabis leaders and cannabis trends driving the global sector. www.businessofcannabis.com X @bofc_global, @bofc_europeLinkedIn @businessofcannabis, @businessofcannabiseuropeInstagramApple PodcastsPodcasts OnlineYoutube
Next up is episode 7 with Helene Servillon, Founding Partner, Journey One Ventures.Helene Servillon is a Marijuana Ventures 40 under 40 awardee who has been investing in the cannabis industry since 2018. She is the Founding Partner of JourneyOne Ventures, an early to growth stage fund that invests at the frontier of wellness industries across software, biotech and consumer companies that innovate in physical, mental, sexual, financial, and social wellness.Join us as our host Shahbaaz Kara-Virani chats with Helene about unlocking international markets, building a flourishing buisness and the international cannabis landscape at Cannabis Europa 2024.Business of Cannabis is a cannabis industry platform marrying cannabis news, video and podcast content, newsletters and online and real-world cannabis events. This channel highlights the cannabis companies, cannabis brands, cannabis leaders and cannabis trends driving the global sector. www.businessofcannabis.com X @bofc_global, @bofc_europeLinkedIn @businessofcannabis, @businessofcannabiseuropeInstagramApple PodcastsPodcasts OnlineYoutube
Next up is episode 6 with Nikos Beis, CEO & Vice President of the Board, Tikun Olam Europe.Nikos Beis is an experienced executive with over 15 years of expertise in banking, real estate, and a profound dedication to the European cannabis sector for over 6 years. As a dynamic and results-oriented CEO, he excels in navigating intricate regulatory frameworks, spearheading strategic endeavors, and fostering sustainable growth within the rapidly evolving cannabis market.Join us as our host Shahbaaz Kara-Virani chats with Nikos about the future of the European cannabis landscape at Cannabis Europa 2024.Business of Cannabis is a cannabis industry platform marrying cannabis news, video and podcast content, newsletters and online and real-world cannabis events. This channel highlights the cannabis companies, cannabis brands, cannabis leaders and cannabis trends driving the global sector. www.businessofcannabis.com X @bofc_global, @bofc_europeLinkedIn @businessofcannabis, @businessofcannabiseuropeInstagramApple PodcastsPodcasts OnlineYoutube
State of Play Session: Ukraine ◦ Olha Stefanyshyna - Member of Parliament (MP), Parliament of Ukraine◦ Hanna Hlushchenko - CEO, Ukrainian Cannabis Consulting GroupHistorically, Ukraine was a significant producer of hemp, cultivating over 150,000 hectares by the 1950s - primarily for oil and fiber. In 2019, a petition to legalise medical cannabis garnered momentum and by 2020, a referendum demonstrated 64.88% public support for medical cannabis. In 2023, Ukraine's parliament approved the legalisation of medical cannabis, which was signed into law, February 2024. This panel discusses the state of play in Ukraine, concerning advocacy groups, pilot programs, medical professionals, and progressive politicians who have championed legislative change.Get tickets for 2025 at www.cannabis-europa.com#cannabisindustry #cannabisbusiness #europe
Next up is episode 5 with Pat Cash, the 1987 Wimbledon Men's Singles Tennis Champion.Post-retirement in 1997, he transitioned into coaching elite players and hosting tennis-focused shows like CNN's Open Court. Despite enduring 14 sports-related surgeries, Cash remains active, crediting #CBD oil for alleviating his injuries. Recently, Cash announced plans to launch his own CBD product line, aiming to advocate for wider CBD accessibility globally. Check out the write-up on Cannabis Health here.Join us as our host Shahbaaz Kara-Virani chats with Pat at Cannabis Europa 2024. Business of Cannabis is a cannabis industry platform marrying cannabis news, video and podcast content, newsletters and online and real-world cannabis events. This channel highlights the cannabis companies, cannabis brands, cannabis leaders and cannabis trends driving the global sector. www.businessofcannabis.comX @bofc_global, @bofc_europe LinkedIn @businessofcannabis, @businessofcannabiseuropeInstagramApple PodcastsPodcasts OnlineYoutube
State of Play Session: The Netherlands ◦ Paul Depla - Mayor of the city of Breda, Gemeente Breda◦ Simone van Breda - Chairman of the Union of Coffeeshop Retailers, Bond van Cannabis Detaillisten◦ Kaj Hollemans - Consultant, KH Legal Advice◦ Tjalling Erkelens - CEO & Chairman of the Board, BedrocanThough the #Netherlands may be synonymous with cannabis liberalisation in Europe, its legal cannabis market has had a long and nuanced history. With the first phase of its controlled cannabis supply chain experiment launching in December 2023, the initial results of this trial are now beginning to filter through, with many more municipalities due to come online over the next few months. In this State of Play Session, the panel examines the continued regulatory and practical barriers facing the experiment, alongside the Netherlands' rich history as a pioneer for cannabis reform.Get tickets for 2025 at www.cannabis-europa.com#cannabisindustry #cannabisbusiness #europe
Next up is episode 4 with Chris Violas, CEO of BLAZE.BLAZE was developed by former cannabis operators and tech entrepreneurs who understand the unique challenges that dispensaries encounter daily. The software is designed to be flexible, accommodating various fulfillment methods and compatible with multiple hardware configurations. BLAZE provides a comprehensive suite of tools for dispensaries and delivery services. The BLAZE team, consisting of former operators and industry experts, is dedicated to automating the daily tasks and compliance needed to run a successful business.Join us as our host Shahbaaz Kara-Virani chats with Chris at Cannabis Europa 2024.Business of Cannabis is a cannabis industry platform marrying cannabis news, video and podcast content, newsletters and online and real-world cannabis events. This channel highlights the cannabis companies, cannabis brands, cannabis leaders and cannabis trends driving the global sector. www.businessofcannabis.comX @bofc_global, @bofc_europe LinkedIn @businessofcannabis, @businessofcannabiseuropeInstagram @businessofcannabisApple: http://bofc.me/applepodPodcasts Online: https://bofc.me/bofclive
State of Play Session: Greece
Next up is episode 3, with CEO of Project Evolve and Co-Founder of the GCNC Chris Day.Chris is the co-founder of the Global Cannabis Network Collective and CEO of Project Evolve, with over 25 years of experience in corporate reinvention, small business growth, and marketing excellence. Join us as our host Shahbaaz Kara-Virani chats with Chris about some of the issues the GCNC is tackling today. Business of Cannabis is a cannabis industry platform marrying cannabis news, video and podcast content, newsletters and online and real-world cannabis events. This channel highlights the cannabis companies, cannabis brands, cannabis leaders and cannabis trends driving the global sector. www.businessofcannabis.comTwitter: www.twitter.com/bofc_global / www.twitter.com/bofc_europeLinkedIn: www.linkedin.com/company/businessofcannabisInstagram: www.instagram.com/businessofcannabisFacebook: www.facebook.com/bofcmediaApple: http://bofc.me/applepodPodcasts Online: https://bofc.me/bofclive
This fireside discussion offers a deep dive into the expansion plans and business objectives for Curaleaf International; their strategies for entering new global markets, potential regulatory challenges, and how they plan to leverage their position as a leading cannabis company. Join us at Cannabis Europa 2025 www.cannabis-europa.com Keep up to date with the company's vision for global growth, potential partnerships, and innovations in product offerings. Join us for a fireside chat with Curaleaf Executive Chairman, Boris Jordan and Omar Sacirbey, Editor at MJBiz Magazine.
Episode 2 is here, and this time Luc Richner joins Shahbaaz in the hot seat to chat about his journey, Switzerland and sustainable cannabis business models in the future. If you don't know Luc, he's the CEO and co-founder of Vigia, the company behind the compliance software suite Cannavigia. With over 12 years of experience in building and managing companies across various industries in Europe, the Middle East, and Southeast Asia, it's fair to say he's an accomplished entrepreneur.
This quarter two seismic shifts occurred in the United States and Germany with a common denominator: the DEA advanced the rescheduling of cannabis from a narcotic to a Class III drug in the USA, and Germany completed the rescheduling with passage of the Cannabis Reform Law April 1. However, the implications are different for the two largest cannabis markets. Join us for a fireside chat with Arthur de Cordova, a former Country Manager for AstraZeneca in Europe, and CEO of Ziel.
Strap in for Episode 1 of our brand new series, Business of Cannabis: Podcast at Cannabis Europa 2024. Kicking things off, CEO of Ziel, Arthur de Cordova joins our host Shahbaaz Kara at the Barbican Centre during our recent Cannabis Europa event - Europe's gateway to global cannabis and thought leadership.
This week's stories:In a major development for the US cannabis industry, Members of the Senate Banking Committee have voted to approve the SAFER Banking Act, paving the way for its final vote in the Senate. Wisconsin lawmakers have introduced a new bill which would legalise adult-use cannabis consumption, the possession of up to five ounces for over 21s, and remove criminal penalties for those under 21.In a bid to expand patient access to medical cannabis in New York, the OCM has expanded its RO Applications Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
This week's stories:Subversive Capital Advisor, which focuses on emerging sectors, this week launched a new cannabis- focused ETF, stating that a ‘regulatory move to Schedule III status meaningfully changes the trajectory for this business.The text for the SAFE Banking Act that aims to transform banking for the cannabis industry has been amended.According to Marijuana Moment, which has seen a copy of the amended text, the bill's updates relate to guidance, finance regulations and reporting requirements.Canopy Growth Corporation announced that it was seeking to raise up to $50m in additional funding via a ‘private placement offering'. Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
This week's stories:General New York Cannabis Licence Applications to Open on October 04Cannabis Sales in New Mexico Reach a Record HighNew Jersey Proposes Rules to Expand Cannabis EdiblesThe UK ‘Perfectly Poised' To Be Central Hub For Global Cannabis Financial Trade Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
This week's stories:Rescheduling cannabis from Schedule I to Schedule III under federal law is “not enough” as it “continues to misrepresent the plant's safety relative to other controlled substances”. But who said it? Listen to find out!On Tuesday, as the US senate returned from its August recess, the majority leader Chuck Schumer reiterated his commitment to advancing the highly anticipated Secure and Fair Enforcement (SAFE) Banking Act.In a letter to New York's governor, four cannabis companies have highlighted the mess of New York's adult-use cannabis programme rollout, calling on the state to issue retail licences. Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
This week's stories:The U.S Department of Health and Human Services (HHS) has sent a letter to the Drug Enforcement Administration (DEA) recommending that cannabis be reclassified from Schedule I to Schedule IIINew York has seen its cannabis licensing process draw to a complete halt after a temporary injunction was implemented on New York's Conditional Adult-Use Retail Dispensary (CAURD) scheme.Canadian cannabis companies are increasingly turning to the international medical cannabis market, seeing exports increase by 50% last year.The report we mention in the episode - Pharmaceutical Cannabis Report: 3rd EditionAre you following the podcast yet? If not, why not? Correct this at once, here -> Follow
This week's stories:Discover How High Fees are Challenging Cannabis Profits – Insights from Health Canada ReportLegal Battles, Licences Revoked – Inside the Alabama Medical Cannabis Commission's TurmoilCalifornia's Tax Cuts for Cannabis: Unveiling the Strategy to Save a Struggling IndustryAre you following the podcast yet? If not, why not? Correct this at once, here -> Follow
This week's stories:US cannabis businesses are bracing for increasing threats from criminals following Mastercard's decision to ban cannabis purchases.US organisation Doctors for Cannabis Regulation (DCR) and other industry stakeholders, are urging the United States and global cannabis regulators to adopt the International Intoxicating Cannabinoid Product SymbolOhio could see potential annual tax revenue from adult-use cannabis hit $276 million in year five of an operational cannabis market to $403 million in year five of operations.Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow
Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow